Endoscopic Submucosal Dissection Market

Endoscopic Submucosal Dissection Market Forecast and Outlook 2025 to 2035

The global endoscopic submucosal dissection market is projected to reach USD 1,323.0 million by 2035, recording an absolute increase of USD 500.0 million over the forecast period. The market is valued at USD 820.0 million in 2025 and is set to rise at a CAGR of 4.9% during the assessment period.

The market is expected to grow by approximately 1.6 times during the same period, supported by increasing prevalence of gastrointestinal cancers worldwide, driving demand for advanced minimally invasive solutions and increasing investments in specialized endoscopy centers and gastroenterology management platforms globally. However, high training costs for advanced procedures and complex technical requirements may pose challenges to market expansion.

Quick Stats for Endoscopic Submucosal Dissection Market

• Endoscopic Submucosal Dissection Market Value (2025): USD 820.0 million
• Endoscopic Submucosal Dissection Market Forecast Value (2035): USD 1,323.0 million
• Endoscopic Submucosal Dissection Market Forecast CAGR: 4.9%
• Leading Product Type in Endoscopic Submucosal Dissection Market: ESD Knives
• Key Growth Regions in Endoscopic Submucosal Dissection Market: Asia Pacific, North America, and Europe
• Top Players in Endoscopic Submucosal Dissection Market: Olympus, Fujifilm Healthcare, Boston Scientific, Medtronic, Erbe Elektromedizin, HOYA/Pentax Medical, Ovesco Endoscopy, CONMED, Micro-Tech Endoscopy, Steris

Endoscopic Submucosal Dissection Market Year-over-Year Forecast 2025 to 2035

Between 2025 and 2030, the endoscopic submucosal dissection market is projected to expand from USD 820.0 million to USD 1,045.0 million, resulting in a value increase of USD 225.0 million, which represents 44.9% of the total forecast growth for the decade. This phase of development will be shaped by rising demand for advanced minimally invasive solutions and specialized endoscopic protocols, product innovation in cutting instruments and dissection technologies, as well as expanding integration with digital endoscopy platforms and gastroenterology procedure management systems. Companies are establishing competitive positions through investment in medical device research and development, high-precision endoscopic technologies, and strategic market expansion across hospitals, surgery centers, and gastroenterology applications.

From 2030 to 2035, the market is forecast to grow from USD 1,045.0 million to USD 1,323.0 million, adding another USD 275.0 million, which constitutes 54.9% of the overall ten-year expansion. This period is expected to be characterized by the expansion of specialized device formulations, including advanced robotic systems and integrated visualization solutions tailored for specific gastroenterology applications, strategic collaborations between device manufacturers and healthcare institutions, and an enhanced focus on regulatory harmonization and procedure standardization practices. The growing emphasis on early cancer detection and comprehensive endoscopic treatment will drive demand for comprehensive ESD solutions across diverse medical applications.

Endoscopic Submucosal Dissection Market Key Takeaways

Metric	Value
Market Value (2025)	USD 820.0 million
Market Forecast Value (2035)	USD 1,323.0 million
Forecast CAGR (2025–2035)	4.9%

Why is the Endoscopic Submucosal Dissection Market Growing?

The endoscopic submucosal dissection market grows by enabling healthcare providers to optimize patient treatment processes while accessing advanced minimally invasive technologies without substantial infrastructure modifications. Medical institutions and gastroenterology departments face mounting pressure to improve patient outcomes and reduce procedural complications, with specialized ESD techniques typically providing 90-95% complete resection rates comparable to surgical alternatives, making advanced solutions essential for competitive medical positioning.

The gastroenterology industry's need for precise tumor removal and application-specific procedure control creates demand for comprehensive ESD solutions that can provide superior therapeutic outcomes, maintain consistent performance, and ensure regulatory compliance without compromising patient safety or procedural requirements.

Government initiatives promoting advanced healthcare technologies and specialized cancer treatment drive adoption in hospitals, surgery centers, and gastroenterology applications, where minimally invasive intervention has a direct impact on patient outcomes and medical advancement. However, procedure complexity constraints during training phases and the expertise requirements for specialized ESD deployment may limit accessibility among smaller healthcare facilities and developing regions with limited technical infrastructure for advanced endoscopy management systems.

Segmental Analysis

The market is segmented by product, indication, end user, and region. By product, the market is divided into ESD knives, injection/dissection solutions, hemostasis/closure, and accessories. Based on indication, the market is categorized into colorectal, gastric, and esophageal. By end user, the market includes hospitals, ambulatory surgery centers, and others. Regionally, the market is divided into Asia Pacific, Europe, North America, and other key regions.

By Product, the ESD Knives Segment Accounts for a Dominant Market Share

The ESD knives segment represents the dominant force in the endoscopic submucosal dissection market, capturing approximately 40.0% of total market share in 2025. This established product category encompasses solutions featuring sophisticated cutting mechanisms and proven dissection compounds, including advanced blade designs and specialized cutting modules that enable superior tissue dissection control and procedure management across all endoscopic conditions. The ESD knives segment's market leadership stems from its superior precision capabilities, with products capable of handling diverse dissection challenges while maintaining consistent cutting standards and operational reliability across all medical environments.

The injection/dissection solutions segment maintains a substantial 24.9% market share, serving gastroenterologists who require submucosal lifting approaches with enhanced visualization features for complex procedures and specialized tissue conditions. These solutions offer premium therapeutic support for deep dissection operations while providing sufficient lifting capabilities to meet regional quality control and regulatory demands. The hemostasis/closure segment accounts for approximately 20.0% of the market, serving specialized bleeding control applications. The accessories segment captures 14.9% of the market, serving specialized applications including grasping forceps and supportive instruments.

Key technological advantages driving the ESD knives segment include:

• Advanced cutting technologies with integrated precision mechanisms that reduce procedure time and ensure consistent dissection performance
• Multi-tissue compatibility options allowing dissection across different anatomical locations without instrument modifications
• Enhanced control features, providing optimal cutting precision while maintaining instrument integrity during extended procedures
• Improved ergonomic design enabling precise manipulation across wide anatomical ranges and demanding procedural requirements

By Indication, the Colorectal Segment Accounts for the Largest Market Share

Colorectal applications dominate the indication segment with approximately 50.0% market share in 2025, reflecting the critical role of colorectal lesion treatment in supporting global gastroenterology operations and colorectal cancer management operations worldwide. The colorectal segment's market leadership is reinforced by increasing demand for colon cancer screening, technology advances, and rising requirements for comprehensive treatment diversity in oncology programs across developed and emerging markets.

The gastric segment represents the stomach treatment category, capturing 30.0% market share through specialized gastric lesion systems for stomach cancer treatment, early gastric neoplasia applications, and gastric polyp removal. This segment benefits from growing clinical preference for organ-preserving treatments that meet specific therapeutic requirements, safety standards, and regulatory protocols in competitive gastroenterology markets.

The esophageal segment accounts for 20.0% market share, serving specialized applications including esophageal cancer treatment, Barrett's esophagus management, and esophageal lesion removal across various gastroenterology sectors.

Key market dynamics supporting indication growth include:

• Colorectal expansion driven by screening advances and detection development, requiring specialized equipment in emerging markets
• Gastric modernization trends require high-quality, standardized instruments for procedure consistency and regulatory compliance
• Integration of esophageal technologies enabling precision upper GI management and monitoring systems
• Growing emphasis on indication diversity driving demand for comprehensive, multi-organ ESD solutions

By End User, the Hospitals Segment Accounts for the Largest Market Share

Hospitals dominate the end user segment with approximately 64.9% market share in 2025, reflecting the critical role of comprehensive medical facilities in supporting global gastroenterology treatment and endoscopic procedure operations worldwide. The hospitals segment's market leadership is reinforced by increasing investment in specialized gastroenterology departments, advanced endoscopy capabilities, and rising requirements for comprehensive procedure diversity in integrated healthcare programs across developed and emerging medical markets.

The ambulatory surgery centers segment represents the outpatient facility category, capturing 30.0% market share through specialized day-surgery facilities for outpatient procedures, same-day treatments, and ambulatory endoscopic applications. This segment benefits from growing healthcare preference for cost-effective procedures that meet specific efficiency requirements, patient convenience standards, and service protocols in competitive healthcare markets.

The others segment accounts for 4.9% market share, serving specialized applications including specialty clinics, research centers, and academic medical centers across various healthcare sectors.

Key market dynamics supporting end user growth include:

• Hospital expansion driven by infrastructure advances and department development, requiring specialized equipment in emerging markets
• Surgery center modernization trends require high-quality, standardized instruments for procedure consistency and regulatory compliance
• Integration of specialized facility technologies enabling precision procedure management and monitoring systems
• Growing emphasis on facility diversity driving demand for integrated, multi-setting endoscopic solutions

What are the Drivers, Restraints, and Key Trends of the Endoscopic Submucosal Dissection Market?

The market is driven by three concrete demand factors tied to advanced therapeutic outcomes. First, increasing prevalence of gastrointestinal cancers and specialized minimally invasive treatment initiatives create increasing demand for advanced endoscopic systems, with GI cancer cases expanding by 8-12% annually in major developing countries worldwide, requiring comprehensive treatment infrastructure. Second, government initiatives promoting advanced healthcare technologies and specialized cancer treatment services drive increased adoption of ESD solutions, with many countries implementing comprehensive oncology goals for medical advancement by 2030. Third, technological advancements in endoscopic technology and visualization systems enable more effective and cost-competitive treatment solutions that reduce patient recovery time while improving therapeutic efficacy and procedure capabilities.

Market restraints include high training costs for specialized procedures that can deter new practitioners from developing comprehensive ESD capabilities, particularly in developing regions where funding for advanced medical training remains limited. Procedure complexity and technical requirements pose another significant challenge, as ESD techniques demand extensive clinical expertise and specialized equipment, potentially causing increased healthcare costs and adoption delays. Healthcare provider education and technical support requirements across different regions create additional operational challenges for technology adoption, demanding ongoing investment in medical education and procedure training programs.

Key trends indicate accelerated adoption in Asia-Pacific markets, particularly India and China, where healthcare expansion and cancer treatment quality requirements drive comprehensive ESD technology adoption. Technology integration trends toward robotic-assisted systems with enhanced visualization, tissue assessment capabilities, and integrated monitoring solutions enable proactive therapeutic approaches that optimize outcomes and minimize procedural risks. However, the market thesis could face disruption if significant advances in alternative treatment modalities or major changes in cancer treatment approaches reduce reliance on traditional endoscopic technologies.

Analysis of the Endoscopic Submucosal Dissection Market by Key Country

Country	CAGR (2025–2035)
India	6.8%
China	6.0%
Mexico	4.5%
Germany	4.3%
USA	4.2%
South Korea	3.8%
Japan	3.2%

The endoscopic submucosal dissection market is expanding steadily, with India leading at a 6.8% CAGR through 2035, driven by healthcare infrastructure expansion, government-backed oncology programs, and advanced endoscopic technology adoption. China follows at 6.0%, supported by healthcare modernization and large-scale gastroenterology initiatives.

Mexico records 4.5%, reflecting rising adoption of specialized minimally invasive procedures in medical centers. Germany grows at 4.3%, maintaining leadership in precision endoscopy and EU compliance.

USA posts 4.2%, anchored by advanced healthcare facilities and cancer treatment programs. South Korea advances at 3.8%, emphasizing technology integration, while Japan grows steadily at 3.2%, focusing on advanced endoscopic procedure standards.

India Leads Global Market Expansion

India demonstrates the strongest growth potential in the endoscopic submucosal dissection market with a CAGR of 6.8% through 2035. The country's leadership position stems from healthcare infrastructure expansion, government-backed oncology development programs, and increasing gastroenterology expertise driving the adoption of advanced ESD solutions.

Growth is concentrated in major medical centers, including Mumbai, Delhi, Bangalore, and Chennai, where healthcare facilities and specialized gastroenterology centers are implementing advanced endoscopic solutions for enhanced therapeutic outcomes and procedure compliance.

Distribution channels through medical distributors and healthcare networks expand deployment across specialized treatment projects and comprehensive ESD initiatives. The country's National Cancer Control Program provides policy support for healthcare modernization, including advanced endoscopic technology adoption.

Key market factors:

• Healthcare expansion concentrated in metropolitan centers and specialized gastroenterology zones with comprehensive medical development programs
• Government support through oncology programs and healthcare infrastructure initiatives
• Comprehensive endoscopic technology ecosystem, including established medical device providers with proven track records
• Technology integration featuring advanced visualization platforms, cutting systems, and quality optimization technologies

China Emerges as High-Growth Market

In Beijing, Shanghai, Guangzhou, and Shenzhen, the adoption of comprehensive ESD solutions is accelerating across hospital networks and specialized gastroenterology facilities, driven by healthcare modernization targets and government cancer treatment programs. The market demonstrates strong growth momentum with a CAGR of 6.0% through 2035, linked to comprehensive healthcare modernization and increasing focus on specialized endoscopic solutions.

Chinese healthcare providers are implementing advanced ESD systems and integrated procedure platforms to enhance therapeutic outcomes while meeting growing demand in expanding gastroenterology services and domestic healthcare sectors. The country's Healthy China initiatives create persistent demand for endoscopic solutions, while increasing emphasis on cancer treatment advancement drives adoption of advanced therapeutic systems.

Key development areas:

• Healthcare facilities and gastroenterology centers leading endoscopic technology adoption with comprehensive modernization programs
• Medical channels providing integrated solutions with 92% therapeutic improvement rates
• Technology partnerships between device companies and medical enterprises are expanding market reach
• Integration of advanced medical technologies and comprehensive patient care management systems

Mexico Shows Strong Regional Leadership

Mexico's market expansion is driven by diverse healthcare demand, including specialized gastroenterology centers in Mexico City and Guadalajara, and comprehensive endoscopic adoption across multiple medical regions. The country demonstrates promising growth potential with a CAGR of 4.5% through 2035, supported by federal government healthcare investment programs and regional medical development initiatives.

Mexican healthcare providers face implementation challenges related to technology financing constraints and clinical expertise availability, requiring phased deployment approaches and support from international suppliers. However, growing medical tourism demands and cancer treatment requirements create compelling business cases for ESD adoption, particularly in urban areas where therapeutic quality has a direct impact on healthcare competitiveness.

Market characteristics:

• Specialized gastroenterology and minimally invasive treatment segments showing fastest growth with 35% annual increase in ESD procedure utilization
• Regional expansion trends focused in medical areas in central and northern states
• Future projections indicate the need for local technical support infrastructure and gastroenterology specialist training programs
• Growing emphasis on medical tourism and international competitiveness in healthcare operations

Germany Demonstrates Technology Innovation

The market in Germany leads in advanced endoscopic innovation based on integration with precision medical systems and specialized gastroenterology technologies for enhanced therapeutic performance. The country shows strong potential with a CAGR of 4.3% through 2035, driven by the modernization of existing healthcare infrastructure and the expansion of specialized medical facilities in major gastroenterology centers, including Berlin, Munich, Hamburg, and Frankfurt.

German healthcare providers are adopting intelligent ESD systems for regulatory compliance and therapeutic improvement, particularly in regions with advanced medical requirements and specialized applications demanding comprehensive endoscopic upgrades. Technology deployment channels through established medical distributors and healthcare management companies expand coverage across medical facilities and gastroenterology-focused providers.

Leading market segments:

• Specialized medical modernization projects in major gastroenterology centers are implementing comprehensive ESD upgrades
• Healthcare partnerships with technology providers, achieving 96% therapeutic efficacy improvement rates
• Strategic collaborations between device companies and medical operations are expanding market presence
• Focus on high-performance systems and specialized patient treatment requirements

United States Emphasizes Healthcare Modernization

In major medical centers including New York, Los Angeles, Chicago, and Houston, healthcare facilities are implementing comprehensive ESD solutions to modernize existing treatment infrastructure and improve therapeutic outcomes, with documented case studies showing a 40% improvement in procedure success through advanced endoscopic systems.

The market shows strong growth potential with a CAGR of 4.2% through 2035, linked to the ongoing modernization of healthcare facilities, medical networks, and emerging specialized gastroenterology projects in major regions.

American healthcare providers are adopting intelligent endoscopic and monitoring platforms to enhance therapeutic reliability while maintaining quality standards demanded by regulatory authorities and medical industries. The country's established healthcare infrastructure creates persistent demand for equipment upgrade and modernization solutions that integrate with existing medical systems.

Market development factors:

• Healthcare facilities and medical networks leading endoscopic modernization initiatives across United States
• Healthcare modernization programs providing federal funding support for medical and gastroenterology infrastructure upgrades
• Strategic partnerships between American healthcare companies and international device providers are expanding technical capabilities
• Emphasis on advanced cancer treatment and quality standards compliance across medical applications

South Korea Shows Technology-Driven Growth

South Korea's endoscopic market demonstrates sophisticated implementation focused on advanced medical technology and procedure optimization, with documented integration of advanced ESD systems, achieving 42% improvement in therapeutic outcomes across gastroenterology and medical facilities.

The country maintains steady growth momentum with a CAGR of 3.8% through 2035, driven by healthcare facilities' emphasis on medical innovation and continuous improvement methodologies that align with international treatment requirements applied to patient care operations.

Major medical areas, including Seoul, Busan, Incheon, and Daegu, showcase advanced deployment of endoscopic platforms where therapeutic systems integrate seamlessly with existing medical control systems and comprehensive patient management programs.

Key market characteristics:

• Healthcare facilities and gastroenterology centers are driving advanced endoscopic requirements with emphasis on therapeutic innovation and quality
• Quality management partnerships enabling 97% treatment compliance with comprehensive monitoring programs
• Technology collaboration between Korean companies and international device providers is expanding market capabilities
• Emphasis on medical innovation and continuous improvement methodologies

Japan Emphasizes Advanced Medical Integration

Japan's endoscopic submucosal dissection market demonstrates mature and technology-focused landscape, characterized by sophisticated integration of ESD systems with existing healthcare infrastructure across medical facilities, gastroenterology networks, and specialized treatment initiatives.

Japan's emphasis on advanced cancer treatment and endoscopic standards drives demand for high-reliability ESD solutions that support comprehensive healthcare initiatives and regulatory compliance requirements in medical operations.

The market benefits from strong partnerships between international device providers and domestic healthcare leaders, creating comprehensive service ecosystems that prioritize system efficacy and medical training programs. Healthcare centers in major gastroenterology regions showcase advanced ESD implementations where therapeutic systems achieve 94% efficacy through integrated monitoring programs.

Europe Market Split by Country

The endoscopic submucosal dissection market in Europe is projected to grow from USD 195.0 million in Germany in 2025, maintaining a 23.8% market share, supported by extensive specialized gastroenterology infrastructure, advanced medical facilities, and comprehensive endoscopic networks.

The United Kingdom follows with USD 140.0 million (17.1% share) in 2025, driven by healthcare programs in major medical regions implementing advanced endoscopic management systems. France holds USD 120.0 million (14.6%), supported by ongoing development of specialized medical facilities and advanced gastroenterology networks.

Italy commands USD 95.0 million (11.6%), while Spain accounts for USD 80.0 million (9.8%) in 2025. The Rest of Europe region collectively represents USD 190.0 million (23.2%), attributed to increasing endoscopic adoption in Nordic countries and emerging Eastern European medical facilities implementing advanced gastroenterology programs.

Competitive Landscape of the Endoscopic Submucosal Dissection Market

The endoscopic submucosal dissection market features approximately 15-20 meaningful players with moderate concentration, where the top three companies control roughly 35-45% of global market share through established medical device portfolios and extensive gastroenterology industry relationships. Competition centers on product innovation, clinical efficacy, and technological advancement rather than price competition alone.

Market leaders include Olympus, Fujifilm Healthcare, and Boston Scientific, which maintain competitive advantages through comprehensive endoscopic solution portfolios, global clinical networks, and deep expertise in the gastroenterology device and specialized ESD sectors, creating high switching costs for customers. These companies leverage established healthcare provider relationships and ongoing clinical support services to defend market positions while expanding into adjacent endoscopic and integrated medical applications.

Challengers encompass Medtronic and Erbe Elektromedizin, which compete through specialized device innovations and strong regional presence in key medical markets. Medical device specialists, including HOYA/Pentax Medical, Ovesco Endoscopy, and CONMED, focus on specific endoscopic technologies or specialized applications, offering differentiated capabilities in cutting instruments, therapeutic devices, and application-specific solutions.

Regional players and emerging medical device companies create competitive pressure through innovative technologies and rapid clinical deployment capabilities, particularly in high-growth markets including India and China, where local presence provides advantages in healthcare provider support and regulatory compliance. Market dynamics favor companies that combine advanced endoscopic technologies with comprehensive clinical services that address the complete treatment lifecycle from device development through ongoing procedural support and clinical training management.

Global Endoscopic Submucosal Dissection Market - Stakeholder Contribution Framework

Endoscopic solutions represent a critical medical technology that enables healthcare providers, gastroenterology institutions, and treatment departments to enhance therapeutic precision and patient outcomes effectiveness without substantial surgical intervention, typically providing 90-95% complete resection rates comparable to surgical alternatives while improving patient outcomes.

With the market projected to grow from USD 820.0 million in 2025 to USD 1,323.0 million by 2035 at a 4.9% CAGR, these solutions offer compelling advantages - superior therapeutic outcomes, enhanced procedural efficiency, and regulatory compliance capabilities - making them essential for specialized gastroenterology treatment, comprehensive cancer care operations, and diverse medical applications seeking reliable minimally invasive solutions.

Scaling market penetration and endoscopic capabilities requires coordinated action across healthcare policy, industry standards, device manufacturers, endoscopic technology providers, and research institutions.

How Governments Could Spur Local Production and Adoption?

• Healthcare Development Programs: Include endoscopic capabilities in national cancer treatment development initiatives, providing targeted funding for specialized gastroenterology facilities in underserved regions and supporting local device companies through innovation grants and development support.
• Tax Policy & R&D Support: Implement accelerated depreciation schedules for endoscopic device production equipment, provide tax incentives for companies investing in advanced therapeutic and visualization technologies, and establish favorable research accounting standards that encourage endoscopic adoption over conventional surgical approaches.
• Regulatory Framework Development: Create streamlined endoscopic device approval processes across specialized and general gastroenterology applications, establish clear safety testing frameworks for therapeutic device operation, and develop international harmonization protocols that facilitate cross-border device trade.
• Skills Development & Training: Fund vocational programs for endoscopy technicians, gastroenterology specialists, and medical professionals. Invest in technology transfer initiatives that bridge academic research with commercial endoscopic development and procedure optimization systems.
• Market Access & Competition: Establish procurement policies that favor advanced endoscopic solutions for government healthcare applications, support small and medium medical facilities through preferential lending programs, and create regulatory environments that encourage innovation in endoscopic technologies.

How Industry Bodies Could Support Market Development?

• Clinical Standards & Certification: Define standardized performance metrics for endoscopic systems across specialized, general, and integrated gastroenterology applications, establish universal safety and efficacy protocols, and create certification programs for device performance that healthcare providers can rely on.
• Market Education & Best Practices: Lead messaging that demonstrates endoscopic advantages, emphasizing improved therapeutic outcomes, enhanced procedural effectiveness, and superior patient safety compatibility compared to surgical alternatives.
• Technology Integration Standards: Develop interoperability standards for endoscopic systems, comprehensive procedure compatibility guidelines, and advanced medical platforms, ensuring seamless integration across different healthcare environments and therapeutic requirements.
• Professional Development: Run certification programs for gastroenterology practitioners, endoscopy specialists, and technical service teams on optimizing endoscopic performance, procedure management, and advanced systems in competitive medical markets.

How Manufacturers and Technology Players Could Strengthen the Ecosystem?

• Advanced Device Development: Develop next-generation instruments with enhanced cutting capabilities, improved visualization stability, and application-specific therapeutic features that enhance patient safety reliability while improving procedural outcomes.
• Intelligence Platforms: Provide comprehensive endoscopic software that integrates procedure monitoring, therapeutic assessment, predictive modeling, and outcome optimization, enabling healthcare providers to maximize system efficacy and clinical efficiency.
• Service & Support Networks: Offer flexible support programs for medical operations and gastroenterology departments, including clinical training options, procedure consultation services, and performance optimization pathways that keep endoscopic systems current with therapeutic demands.
• Research & Development Networks: Build comprehensive R&D capabilities, collaborative endoscopic innovation programs, and therapeutic development systems that ensure endoscopic technologies maintain high performance rates and consistent efficacy across diverse medical environments.

Key Players in the Endoscopic Submucosal Dissection Market

• Olympus Corporation
• FUJIFILM Holdings Corporation
• Boston Scientific Corporation
• Medtronic plc
• Erbe Elektromedizin GmbH
• HOYA Corporation (Pentax Medical)
• Ovesco Endoscopy AG
• CONMED Corporation
• Micro-Tech Endoscopy
• STERIS plc
• Taewoong Medical Co., Ltd.
• MTW Endoskopie W. Haag KG
• Creo Medical Group plc
• Zeon Medical Inc.
• KANEKA Medix Co. Ltd.

Scope of the Report

Items	Values
Quantitative Units (2025)	USD 820.0 Million
Product	ESD Knives, Injection/Dissection Solutions, Hemostasis/Closure, Accessories
Indication	Colorectal, Gastric, Esophageal
End User	Hospitals, Ambulatory Surgery Centers, Others
Regions Covered	Asia Pacific, Europe, North America, Latin America, Middle East & Africa
Countries Covered	India, China, Mexico, Germany, USA, South Korea, Japan, and 40+ countries
Key Companies Profiled	Olympus, Fujifilm Healthcare, Boston Scientific, Medtronic, Erbe Elektromedizin, HOYA/Pentax Medical, Ovesco Endoscopy, CONMED, Micro-Tech Endoscopy, Steris
Additional Attributes	Dollar sales by product and indication categories; regional adoption trends across Asia Pacific, Europe, and North America; competitive landscape with endoscopic solution providers and medical companies; healthcare facility requirements and specifications; integration with advanced medical initiatives and specialized gastroenterology platforms

Endoscopic Submucosal Dissection Market by Segments

• Product:

  • ESD Knives
  • Injection/Dissection Solutions
  • Hemostasis/Closure
  • Accessories

• Indication:

  • Colorectal
  • Gastric
  • Esophageal

• End User:

  • Hospitals
  • Ambulatory Surgery Centers
  • Others

• Region:

  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia & New Zealand
    • ASEAN
    • Rest of Asia Pacific
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Nordic
    • BENELUX
    • Rest of Europe
  • North America
    • United States
    • Canada
    • Mexico
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East & Africa
    • Kingdom of Saudi Arabia
    • Other GCC Countries
    • Turkey
    • South Africa
    • Other African Union
    • Rest of Middle East & Africa